A range of reproductive factors, including age when periods first start and an early menopause, are all linked to a heightened risk of COPD—the umbrella term for progressive lung conditions that cause breathing difficulties—finds research published online in the journal Thorax.
Accord BioPharma’s HERCESSI gets FDA approval
HERCESSI is approved for treating HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric or gastroesophageal junction adenocarcinoma. Credit: Lightspring/Shutterstock. Accord BioPharma, the speciality division